ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0725
0,00%
Bitcoin
63.145,40
0,41%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) Notícias

JAZZ Jazz Pharmaceuticals PLC

110,01
0,72 (0,66%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Jazz Pharmaceuticals PLC JAZZ NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,72 0,66% 110,01 19:45:55
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
110,14 108,58 111,55 110,01 109,29
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202417:10PRNUSJazz Pharmaceuticals to Participate in the BofA Securities..
01/05/202417:05PRNUSJazz Pharmaceuticals Announces First Quarter 2024 Financial..
24/04/202417:05PRNUSJazz Pharmaceuticals to Present Data Across Growing Oncology..
17/04/202417:15PRNUSJazz Pharmaceuticals to Report 2024 First Quarter Financial..
10/04/202408:45PRNUSJazz Pharmaceuticals to Showcase Expansive Neuroscience..
02/04/202408:30PRNUSJazz Pharmaceuticals Completes Zanidatamab Biologics License..
12/03/202417:15PRNUSJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
28/02/202418:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
27/02/202409:45PRNUSJazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
21/02/202409:45PRNUSJazz Pharmaceuticals Appoints Philip Johnson as Chief..
20/02/202418:15PRNUSJazz Pharmaceuticals to Participate in Upcoming March..
14/02/202418:15PRNUSJazz Pharmaceuticals to Report 2023 Full Year and Fourth..
07/02/202404:00PRNUSJazz Pharmaceuticals Enters Definitive Agreement with Redx..
21/12/202318:05PRNUSJazz Pharmaceuticals Provides Update on Phase 2 Trial of..
20/12/202318:15PRNUSJazz Pharmaceuticals to Present at the 42nd Annual J.P...
08/12/202315:20PRNUSJazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS..
01/12/202311:02PRNUSJazz Pharmaceuticals to Present Long-Term and Real-World..
30/11/202309:45PRNUSJazz Pharmaceuticals to Present New Data Highlighting..
14/11/202304:00BWAutifony Announces Exclusive Global License and..
08/11/202318:05PRNUSJazz Pharmaceuticals Announces Third Quarter 2023 Financial..
07/11/202309:45PRNUSJazz Pharmaceuticals and MD Anderson Announce Five-Year..
01/11/202317:15PRNUSJazz Pharmaceuticals to Participate in Upcoming November..
25/10/202317:15PRNUSJazz Pharmaceuticals to Report 2023 Third Quarter Financial..
23/10/202308:45PRNUSJazz Pharmaceuticals Presents Data Highlighting the..
18/10/202308:45PRNUSJazz Pharmaceuticals to Present Latest Advancements in Sleep..
16/10/202308:45PRNUSJazz Pharmaceuticals to Showcase Growing Impact in Solid..
21/09/202319:20DJNJazz Pharmaceuticals Gets European Commission OK for..
21/09/202318:41PRNUSJazz Pharmaceuticals Receives European Commission Approval..
20/09/202309:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
13/09/202317:15PRNUSJazz Pharmaceuticals to Participate in Three Upcoming..
12/09/202308:30PRNUSJazz Pharmaceuticals Announces Key Update to Leadership Team
11/09/202308:45PRNUSJazz Pharmaceuticals Showcases Impact of Sleep Medicine..
24/08/202317:40PRNUSJazz Pharmaceuticals to Participate in Citi's 18th Annual..
24/08/202317:23PRNUSJazz Pharmaceuticals to Participate in Citi's 18th Annual..
09/08/202317:05PRNUSJazz Pharmaceuticals Announces Second Quarter 2023 Financial..
02/08/202315:11PRNCAJazz Pharmaceuticals signe une lettre d'intention avec..
02/08/202315:10PRNCAJazz Pharmaceuticals enters into Letter of Intent with the..
26/07/202317:15PRNUSJazz Pharmaceuticals to Report 2023 Second Quarter Financial..
21/07/202309:08PRNUSJazz Pharmaceuticals Receives CHMP Positive Opinion for..
23/06/202316:05DJNAvadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals..
22/06/202319:59DJNJazz Pharmaceuticals Files Complaint Against FDA for..
02/06/202320:23PRNUSJazz Pharmaceuticals and Zymeworks Present Positive Pivotal..
02/06/202319:41PRNUSJazz Pharmaceuticals and Zymeworks Present Positive Pivotal..
31/05/202308:45PRNUSJazz Pharmaceuticals Demonstrates Continued Leadership in..
30/05/202317:26PRNUSJazz Pharmaceuticals to Participate in the 2023 Goldman..
30/05/202317:15PRNUSJazz Pharmaceuticals to Participate in the 2023 Goldman..
25/05/202317:15PRNUSJazz Pharmaceuticals to Host Zanidatamab KOL Investor..
10/05/202317:05PRNUSJazz Pharmaceuticals Announces First Quarter 2023 Financial..

Seu Histórico Recente

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados